CRIS Current Research Information System

ZERBINI, MARIALUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.131
EU - Europa 4.438
AS - Asia 2.296
AF - Africa 255
SA - Sud America 7
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.134
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.106
GB - Regno Unito 1.274
CN - Cina 829
VN - Vietnam 629
DE - Germania 579
UA - Ucraina 575
IT - Italia 526
SE - Svezia 526
SG - Singapore 492
RU - Federazione Russa 271
IN - India 237
FR - Francia 187
IE - Irlanda 171
CH - Svizzera 85
ZA - Sudafrica 85
EE - Estonia 84
TG - Togo 72
SC - Seychelles 48
BG - Bulgaria 42
JP - Giappone 35
BE - Belgio 32
IR - Iran 32
NG - Nigeria 27
CI - Costa d'Avorio 23
CA - Canada 21
GR - Grecia 19
FI - Finlandia 14
NL - Olanda 14
AT - Austria 13
JO - Giordania 11
RO - Romania 11
UZ - Uzbekistan 9
LB - Libano 6
BR - Brasile 4
HK - Hong Kong 4
AU - Australia 3
EU - Europa 3
MY - Malesia 3
CZ - Repubblica Ceca 2
HU - Ungheria 2
IL - Israele 2
LT - Lituania 2
MD - Moldavia 2
PL - Polonia 2
PR - Porto Rico 2
AR - Argentina 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
ES - Italia 1
IQ - Iraq 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
Totale 12.134
Salva come PNG Salva come JPEG
Città #
Southend 1.100
Chandler 540
Ashburn 496
Fairfield 458
Dong Ket 448
Jacksonville 404
Singapore 383
Wilmington 244
Ann Arbor 243
Princeton 239
Seattle 239
Woodbridge 232
Houston 221
Dublin 169
Boardman 161
Cambridge 156
Padova 115
Westminster 115
Nanjing 108
Santa Clara 102
Berlin 85
Bern 78
Medford 73
Lomé 72
Mülheim 69
Saint Petersburg 63
Shenyang 55
Milan 50
Jinan 49
New York 49
Mahé 47
Beijing 42
Sofia 42
Bologna 37
Changsha 37
Redwood City 37
Nanchang 36
Tokyo 35
Tianjin 33
Brussels 32
Hebei 31
Abeokuta 27
Florence 26
San Diego 25
Verona 25
Bremen 24
Abidjan 23
Des Moines 23
Shanghai 23
Guangzhou 22
Zhengzhou 22
Hangzhou 21
Jiaxing 21
Olalla 18
Paris 17
San Venanzo 17
Taizhou 17
Norwalk 16
Toronto 15
Helsinki 14
Ningbo 14
Yubileyny 13
Haikou 12
Phoenix 12
Taiyuan 12
Amman 11
Falls Church 11
Kuban 11
Pune 11
Los Angeles 10
Mountain View 10
Rome 10
Vienna 10
Ardabil 9
Kunming 9
Shijiazhuang 9
Wuhan 9
Dearborn 8
Lanzhou 8
Monmouth Junction 8
Tappahannock 8
Bühl 7
Chongqing 7
Fuzhou 7
Leawood 7
Rimini 7
Shenzhen 7
Zanjan 7
Andover 6
Chengdu 6
Frankfurt Am Main 6
Moscow 6
Quanzhou 6
Augusta 5
Buffalo 5
Changchun 5
Harbin 5
Hefei 5
London 5
Trieste 5
Totale 7.950
Salva come PNG Salva come JPEG
Nome #
A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA 188
Presence of high-risk mucosal human papillomavirus genotypes in primary melanoma and in acquired dysplastic melanocytic naevi 159
Assessment of the presence of mucosal human papillomaviruses in malignant melanomas using combined fluorescent in situ hybridization and chemiluminescent immunohistochemistry 157
Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis 156
Analisi dell’integrazione del DNA di HPV16 in campioni cervicali, mediante PCR qualitativa e quantitativa 156
Comparison of Abbott RealTime High Risk HPV and Hybrid Capture 2 for the detection of high-risk HPV DNA in a referral population setting 155
Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus 151
A proteomic approach to the analysis of B19 capsid proteins 148
Presence and type of oncogenic human papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma 146
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 145
Infezione da Parvovirus B19 nella donna in gravidanza, nel feto e nel neonato. 144
Analysis by real-time PCR of B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines 143
Analysis of Parvovirus B19 DNA methylation status in experimental and natural infections. 143
Analysis of HPV16 E6*I-II transcripts in cervical samples 142
Parvovirus in gravidanza: possibili conseguenze della trasmissione verticale 141
Parvovirus B19 in pregnancy: possible consequences of vertical transmission. 140
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays 138
High-throughput polymerase chain reaction chemiluminescent enzyme immunoassay for typing and quantifying human papillomavirus DNAs 137
Sviluppo di un saggio di Real- Time PCR per la quantificazione del DNA di HPV in campioni citologici cervicali 136
Analisi della competenza funzionale di cloni genomici di parvovirus B19 135
Ricerca e determinazione del carico virale di parvovirus B19 mediante tecnica di Real-time PCR calibrata 133
Comparative evaluation of an automated assay for parvovirus B19 antibody detection 133
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicale in situ 130
Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. 130
Analysis of E6* spliced products of HPV16 as molecular markers of cervical disease progression. 126
Recurrent erythema in patients with long-term parvovirus B19 infection 125
Analysis of splice junctions and polyadenylation sites of parvovirus B19 genome by a PCR-based approach 125
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 125
Application of the NASBA method for the detection of human papillomavirus E6-E7 transcripts in patients treated for high grade CIN and positive to HPV16 124
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 124
Ricerca del parvovirus B19 nello screening per la sicurezza degli emoderivati 123
Analisi funzionale del genoma di parvovirus B19 in due sistemi sperimentali: infezione in vitro e trasfezione con cloni ricombinanti 123
Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis 123
Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias 123
Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions 122
Calibrated real-time PCR for evaluation of parvovirus b19 viral load 120
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicali in situ 120
Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C(HCV) virus RNA in diagnostic virology: a multicentre study (MS) in Italy 119
Correlazione tra presenza del DNA di HPV ed espressione della P16INK4A in lesioni benigne e maligne della vulva 119
Competitive PCR-ELISA protocols for the quantitative and the standardized detection of viral genomes. 119
Analisi della competenza funzionale di cloni genomici di parvovirus B19 per lo sviluppo di vettori virali 119
Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids 117
Presenza e ruolo della metilazione dei dinucleotidi CpG nel DNA di parvovirus B19. 117
Chemiluminescent assay for p16INK4A quantitation in cervical biopsies combined with fluorescent HPV DNA in situ hybridisation 116
Functional analysis and quantitative determination of the expression profile of human parvovirus B19 115
B19 in vitro infection of permissive systems: a quantitative analysis of virus replication and expression 115
High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups. 114
HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ 113
Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment 112
Presence and type of oncogenic human papillomavirus in classic VIN, differentiated VIN and keratinizing VSCC 111
Determination of physical status and viral load of HPV 16 DNA in cytological cervical samples by quantitative PCR assays 111
Evidence of human bocavirus viremia in healthy blood donors. 111
Analysis of the functional competence of genomic clones of Parvovirus B19 111
Rivelazione e caratterizzazione di varianti genotipiche di parvovirus B19 in sangue proveniente da unità trasfusionale 110
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors 109
Sviluppo di un saggio di spettrometria di massa, ad elevata processività, per la ricerca e genotipizzazione di 12 HPV ad alto rischio oncogeno 109
Human papillomavirus in melanoma: reply from authors 108
Espressione e purificazione di gamma-interferon bovino bioattivo in baculovirus 107
Qualitative PCR-ELISA protocol for the detection and typing of viral genomes. 106
Parvovirus B19 genome as a single, two-state replicative and transcriptional unit 106
Evaluation of quantitative PCR assays for the determination of physical status and viral load of HPV16 DNA 105
Follow up of patients treated of HPV 16 high-grade CIN: HPV DNA patterns and disease implication 103
Parvovirus B19 infection during pregnancy and evaluation of fetal outcomes 102
Population-based frequency assessment of HPV-induced lesions in patients with borderline Pap tests in the Emilia-Romagna Region: the PATER study. 102
Lo studio PATER: Population-Based Frequency Assessment of HPV Infections in Borderline Pap Tests in the Emilia-Romagna Region 101
Parvovirus B19-derived fetal complications following gestational infection. 101
Parvovirus B19 DNA Is Commonly Harboured in Human Skin. 101
Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion. 100
Factors predicting the outcome of conservately trated adenocarcinoma in situ of uterine cervix: an analysis of 166 cases 100
Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman 99
High-throughput type-specific detection of HPV using MassARRAY technology 97
Metodo di real time PCR in due step per la definizione di gruppi di rischio di HPV e per la quantificazione genotipo specifica 95
Correlazione tra presenza di HPV, carica e integrazione virale in lesioni (pre)neoplastiche vulvari 95
Comparison of abbott realtime HPV assay and digene HC2 HPV DNA test for the detection of high-risk HPV DNA in a referral population setting Source: JOURNAL OF CLINICAL VIROLOGY Volume: 46 Pages: S49-S49 Supplement: Suppl. 1 Published: SEP 2009 93
Valutazione del rischio di insorgenza di nefropatia associata a polyomavirus nello screening di trapiantati renali 93
Studio dell’espressione di parvovirus B19 in sistemi permissivi e non mediante real-time PCR 92
HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection. 92
Implicazioni nella progressione della patologia cervicale 91
Quantitative evaluation of HBoV DNA in serum samples from Italian population. 91
La biologia molecolare nella diagnosi delle infezioni da HPV 90
Detection of parvovirus B19 IgG: choice of antigens and serological tests 90
Diagnosi virologica di infezione da papillomavirus umani 89
Valutazione della correlazione tra presenza di HPV ed espressione della P16 INK4A in lesioni vulvari e cervicali mediante FISH combinata ad IHC con rivelazione chemiluminescente 89
Colorimetric and chemiluminescent Peptide Nucleic Acid-based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 89
Detection of HPV 16 E6-E7 transcripts in cervical cytological samples and correlation with HPV-DNA physical status 87
Persistent parvovirus B19 infection resulting in carpal tunnel syndrome 87
Valutazione della persistenza di diversi genotipi di HPV nel follow-up di pazienti trattate per lesioni cervicali di alto gradi 86
Functional analysis of B19 virus genome by transcript-specific quantitative real-time PCR 85
Parvovirus B19 in pregnancy: possible consequence of vertical transmission 85
PNA-Based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 84
B19 parvovirus infections: diagnostic technologies 82
Clonazione, espressione e purificazione di g-IFN bovino ricombinante in baculovirus 81
Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions 79
Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination 78
Nuovo saggio FISH per la ricerca del DNA di HPV combinato ad IHC chemiluminescente per la quantificazione di p16 INK4A in lesioni cervicali 78
Ricerca di HPV ad alto rischio oncogeno: Abbott Real Time HPV Assay e Digene HC2 HPV DNA Test a confronto 78
PNA-based probe for quantitative chemiluminescent in situ hybridisation imaging of cellular parvovirus B19 replication kinetics 76
B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines – a quantitative analysis by real-time PCR 76
Expression of bioactive recombinant bovine interferon-gamma using baculovirus 75
Construction and functional analysis of B19 genomic clones 74
Totale 11.274
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.576
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.576
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.037 0 0 0 0 0 0 0 340 275 185 96 141
2020/20211.970 371 109 52 100 27 119 32 101 125 97 105 732
2021/20222.085 140 105 142 226 177 107 25 112 62 215 358 416
2022/20232.233 251 328 120 269 159 140 61 124 349 36 225 171
2023/2024807 38 96 40 131 47 161 114 70 19 34 17 40
2024/20251.372 73 333 211 134 278 104 221 18 0 0 0 0
Totale 12.373